Insys Therapeutics Inc (INSYQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 82,080 | 140,693 | 242,275 | 330,323 | 219,092 |
| Cost of Goods | 10,803 | 20,643 | 25,393 | 28,854 | 22,578 |
| Gross Profit | 71,277 | 120,050 | 216,882 | 301,469 | 196,514 |
| Operating Expenses | 199,803 | 339,724 | 209,949 | 211,867 | 136,102 |
| Operating Income | -127,723 | -219,031 | 7,326 | 90,456 | 60,990 |
| Other Income | 1,316 | 1,836 | 1,098 | 538 | 153 |
| Pre-tax Income | -126,407 | -217,195 | 8,424 | 90,994 | 61,143 |
| Income Tax | -1,900 | 9,640 | 834 | 32,941 | 25,089 |
| Net Income Continuous | -124,507 | -226,835 | 7,590 | 58,053 | 36,054 |
| Net Income | $-124,507 | $-226,835 | $7,590 | $58,053 | $36,054 |
| EPS Basic Total Ops | -1.68 | -3.12 | 0.11 | 0.81 | 0.52 |
| EPS Basic Continuous Ops | -1.68 | -3.12 | 0.11 | 0.81 | 0.52 |
| EPS Diluted Total Ops | -1.68 | -3.12 | 0.10 | 0.77 | 0.49 |
| EPS Diluted Continuous Ops | -1.68 | -3.12 | 0.10 | 0.77 | 0.49 |
| EPS Diluted Before Non-Recurring Items | -1.39 | -0.49 | 0.14 | 1.21 | 0.52 |
| EBITDA(a) | $-120,118 | $-210,569 | $15,604 | $97,178 | $63,857 |